Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • History
    • Divisions
      • Atlanta
        • Atlanta Leadership
        • Atlanta Contacts
      • Caribbean
        • Caribbean Leadership
        • Caribbean Contacts
      • Chicago
        • Chicago Leadership
        • Chicago Contacts
      • Dallas
        • Dallas Leadership
        • Dallas Contacts
      • Detroit
        • Detroit Leadership
        • Detroit Contacts
      • El Paso
        • El Paso Contacts
      • Headquarters
      • Houston
        • Houston Leadership
        • Houston Contacts
      • Los Angeles
        • Los Angeles Leadership
        • Los Angeles Contacts
      • Louisville
        • Louisville Leadership
        • Louisville Contacts
      • Miami
        • Miami Leadership
        • Miami Contacts
      • New England
        • New England Leadership
        • New England Contacts
      • New Jersey
        • New Jersey Leadership
        • New Jersey Contacts
      • New Orleans
        • New Orleans Leadership
        • New Orleans Contacts
      • New York
        • New York Leadership
        • New York Contacts
      • Omaha
        • Omaha Leadership
        • Omaha Contacts
      • Philadelphia
        • Philadelphia Leadership
        • Philadelphia Contacts
      • Phoenix
        • Phoenix Leadership
        • Phoenix Contacts
      • Rocky Mountain
        • Rocky Mountain Contacts
      • San Diego
        • San Diego Leadership
        • San Diego Contacts
      • San Francisco
        • San Francisco Leadership
        • San Francisco Contacts
      • Seattle
        • Seattle Leadership
        • Seattle Contacts
      • St. Louis
        • St. Louis Leadership
        • St. Louis Contacts
      • Washington, DC
        • Washington Leadership
        • Washington Contacts
    • DEA Museum
    • Foreign Divisions
      • Africa
      • Andean
      • Caribbean
      • Europe
      • Asia Pacific
        • Asia Pacific Leadership
      • Middle East
      • North and Central America
      • Southern Cone
    • Operational Divisions
      • Aviation Division
      • Diversion Control Division
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
        • Mission
        • Services
        • Contacts
      • Forensic Sciences
        • Computer Forensics Program
        • Environmental Management
        • Laboratories
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
        • State and Local Task Forces
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
      • Special Agent Job Announcements
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • How to Apply
      • Employment Requirements
      • Equal Opportunity Employer
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
  • Resources
    • Recovery Resources
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Foreign Divisions
    • Operational Divisions
    • Wall of Honor
    • Contact Us
  • What We Do
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • How to Apply
  • Resources
    • Recovery Resources
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Drug Enforcement Administration

William Bodner Special Agent in Charge
Los Angeles
@dealosangeles
July 17, 2017
Contact: Jamie Nassour
Phone Number: (571) 387-3136
For Immediate Release

Reno Doctor Robert Rand Pleads Guilty To Involuntary Manslaughter Of Patient And Unlawful Distribution Of Nearly 24,000 Oxycodone Pills

RENO, N.V. - Local physician Dr. Robert Rand pleaded guilty today to involuntary manslaughter of a patient and unlawful distribution of oxycodone to another patient, announced Acting U.S. Attorney Steven W. Myhre for the District of Nevada. Sentencing is scheduled for Oct. 23, 2017, before U.S. District Judge Miranda Du.  At the time of sentencing, Rand faces a maximum of eight years in prison on the manslaughter count and a maximum of 20 years in prison on the drug count.

Robert Gene Rand, 54, a Nevada-licensed physician who operated Rand Family Care in Reno and eight others, including Richard Winston West II, the former manager of the Jones-West Ford dealership, were indicted on May 11, 2016, with federal prescription drug distribution charges.  A superseding indictment was returned against Rand, the last remaining defendant, on June 21, 2017.

According to admissions made in the plea agreement, Rand prescribed an excessive amount of oxycodone to a patient without a legitimate medical purpose and not in the usual course of professional practice that resulted in the patient’s death from oxycodone intoxication.  From the start of treatment, in June 2014, Rand prescribed the patient 180 oxycodone pills per month.  During this time, the patient was hospitalized twice.  In September 2015, Rand prescribed 45 dosages of oxycodone in 30 mg amounts, as well as Xanax, to the patient.  One week later, Rand prescribed an additional 180 dosages of oxycodone in 30 mg amounts to the patient.  Rand acted with gross negligence in prescribing this oxycodone and did so in reckless regard for the patient’s life.

Furthermore, from March 2011 to April 2016, Rand prescribed another patient a total of 23,645 oxycodone 30 mg pills without a legitimate medical purpose. He prescribed a number of opioids to this patient at the same time, including oxycodone in 5 mg, 10 mg, 20 mg, and 30 mg dosages, Percocet, hydrocodone, fentanyl, as well as other substances, such as carisoprodol and alprazolam.

According to the Centers for Disease Control and (CDC), nearly two million Americans abused or were dependent on prescription opioids in 2014.  Overdose deaths from opioids, including prescription opioids and heroin, have nearly quadrupled since 1999. Overdoses involving opioids killed more than 28,000 people in 2014, more than any year on record, and over one-half of those deaths were from prescription opioids. 

This case is being investigated by the DEA, FBI, IRS Criminal Investigation, Homeland Security Investigations, Bureau of Alcohol, Tobacco, Firearms and Enforcement, Reno Police Department, Washoe County Sheriff’s Office, Carson City Sheriff’s Office, Susanville, California Police Department, Nevada Department of Corrections, Nevada Gaming Control,  Nevada Department of Public Safety,  Lyon County Sheriff’s Office, and the State of Nevada Division of Welfare, Office of Investigations and Recovery.

The case is being prosecuted by Assistant U.S. Attorneys James E. Keller and Shannon M. Bryant.

  • Facebook
  • Twitter
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Drug Prevention
    • Law Enforcement
    • Diversion Control Division
    • News
  • Careers
    • Overview
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
  • Resources
    • Drug Information
    • Employee Assistance Program
    • Equal Opportunity Employer
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
  • Policies
    • Accessibility, Plug-ins & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
Home

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook Twitter LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster